CF
GILD icon

Copperwynd Financial’s Gilead Sciences GILD Stock Holding History

Copperwynd Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,982
Closed -$2.06M – 140
2022
Q4 		$2.06M Buy
+23,982
New +$1.9M 1.16% 16
2018
Q3 		– Sell
-4,773
Closed -$338K – 98
2018
Q2 		$338K Buy
4,773
+138
+3% +$9.74K 0.24% 70
2018
Q1 		$349K Buy
4,635
+578
+14% +$45.9K 0.24% 69
2017
Q4 		$291K Buy
+4,057
New +$308K 0.21% 75

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Copperwynd Financial's GILD Position: Q1 2023 in Review

Copperwynd Financial sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 23,982 shares — an estimated $2.06M sold.

Copperwynd Financial first reported a position in GILD in Q4 2017 and held it in 4 quarters. The position peaked at $2.06M in Q4 2022. 1,736 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Copperwynd Financial reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Copperwynd Financial sold 23,982 Gilead Sciences shares in Q1 2023, an estimated $2.06M.
  • Copperwynd Financial first reported a position in Gilead Sciences in Q4 2017 and held it in 4 quarters.
  • Copperwynd Financial's Gilead Sciences position peaked at $2.06M in Q4 2022.
  • 1,736 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Copperwynd Financial's 13F filing for Q1 2023, filed 28 Apr 2023.